宏基因组二代测序在侵袭性真菌性鼻窦炎诊断中的初步应用
回顾性分析天津市第一中心医院2021年2月至2023年10月收治的14例经鼻窦病变活检标本mNGS确诊的侵袭性真菌性鼻窦炎患者,总结实验室、影像、病理、治疗及预后资料,探讨mNGS的快速诊断价值。14例中11例痊愈无复发,3例术后症状明显改善。
要点
- 14例IFRS患者均经鼻窦病变活检标本mNGS测序确诊,年龄14~77岁,男性8例、女性6例。
- mNGS检出病原体为根霉属7例、曲霉属5例、木霉菌属1例、赛多孢子菌属1例。
- 随访2个月至2年,11例痊愈无复发,3例术后症状明显改善。
核心结论
- mNGS测序技术可作为快速诊断IFRS的检测手段,为IFRS的临床诊疗提供病原学依据,具有良好的临床应用价值。
研究设计与样本
- 回顾性分析天津市第一中心医院2021年2月至2023年10月收治的14例IFRS患者临床资料,其中男性8例、女性6例,年龄14~77岁。
- 所有患者均通过鼻腔鼻窦病变活检标本mNGS测序技术确诊IFRS,对实验室检查、影像学检查、组织病理学检查结果以及治疗方案和预后情况进行总结分析。
主要发现
- 14例患者均确诊为IFRS,mNGS检出根霉属7例、曲霉属5例、木霉菌属1例、赛多孢子菌属1例。
- 随访时间2个月至2年,截至随访结束,14例IFRS患者中11例痊愈,未见复发迹象,3例患者术后症状明显改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: By conducting a retrospective analysis of the clinical data of 14 patients diagnosed with invasive fungal rhinosinusitis (IFRS) confirmed by metagenomics next generation sequencing (mNGS) technology, we aim to explore the rapid diagnosis value of mNGS in IFRS. Methods: The clinical data of 14 IFRS patients admitted to TianJin First Central Hospital were retrospectively analyzed from February 2021 to October 2023. The study cohort comprised 8 males and 6 females, with ages ranging from 14 to 77 years. All patients were diagnosed as IFRS by performing mNGS sequencing technology of nasal sinus lesion biopsy specimens. Clinical data such as laboratory examination, imaging examination, histopathological examination results, treatment plan and prognosis were summarized and analyzed. Results: All 14 patients were diagnosed as IFRS, with mNGS detecting pathogens such as Rhizopus (7 cases), Aspergillus (5 cases), Trichoderma (1 case), and Scedosporium apiospermum (1 case). Follow-up evaluations were conducted for a period ranging from 2 months to 2 years post-treatment. At the end of follow-up, 11 out of 14 IFRS patients achieved a complete cure with no signs of recurrence, while the symptoms of the remaining 3 patients significantly improved with comprehensive treatment. Conclusion: mNGS emerges as a highly effective diagnostic tool for IFRS, providing valuable microbiological evidence for clinical diagnosis and demonstrating promising clinical utility. 目的: 通过回顾性分析14例经宏基因组二代测序(metagenomics next generation sequencing,mNGS)技术确诊侵袭性真菌性鼻窦炎(invasive fungal rhinosinusitis,IFRS)患者的临床资料,探讨mNGS技术在快速确诊IFRS中的应用价值。 方法: 回顾性分析天津市第一中心医院2021年2月至2023年10月期间收治的14例IFRS患者的临床资料,其中男性8例,女性6例,年龄14~77岁。所有患者均通过鼻腔鼻窦病变活检标本mNGS测序技术确诊IFRS,对其实验室检查、影像学检查、组织病理学检查结果,以及治疗方案和预后情况等临床资料进行总结分析。 结果: 14例患者均确诊为IFRS,其中根霉属7例,曲霉属5例,木霉菌属1例,赛多孢子菌属1例。随访时间2个月至2年,截至随访结束,14例IFRS患者中11例痊愈,未见复发迹象,3例患者术后症状明显改善。 结论: mNGS测序技术可作为快速诊断IFRS的检测手段,为IFRS的临床诊疗提供病原学依据,具有良好的临床应用价值。.
引用
- Zhang CT, Liang YB, Zhi JT, et al. [The preliminary application of mNGS in the diagnosis of invasive fungal sinusitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. PMID: 38811177. doi:10.3760/cma.j.cn115330-20231129-00253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。